RecruitingPhase IEN original

This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

This study is a first-in-human (FIH), Phase 1, multicenter, open-label study to determine the safety, tolerability, pharmacokinetics, pharmacodynamics, and evaluate the preliminary anti-tumor activity of LTZ-301 administered as a single agent in adult subjects with relapsed or refractory B-cell non-Hodgkin lymphoma

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • Wiek 18 lat lub więcej
  • Wcześniejsze leczenie co najmniej 2 schematami chemioterapii bez ostatecznego efektu lub z nawrotem choroby
  • Widoczny guz o wymiarach co najmniej 1,5 cm
  • Dobry ogólny stan zdrowia (status performance 0 lub 1)
  • Prawidłowa funkcja szpiku kostnego, serca, płuc, nerek i wątroby

✗ Disqualifies

  • Białaczka limfocytarna lub transformacja Richtera
  • Przeszczep organu lub przeszczep komórek macierzystych
  • Transplantacja autologiczna komórek macierzystych w ciągu ostatnich 100 dni
  • Poprzednia terapia CAR-T w ciągu ostatnich 60 dni
  • Chłoniak ośrodkowego układu nerwowego
  • Zakażenie HIV
  • Aktywna choroba autoimmunologiczna
  • Historia zakrzepicy żyły głębokich w ostatnich 3 miesiącach

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Last updated (source)
July 24, 2026
Sex
No restrictions

Therapies / drugs in trial

Locations (6)

City of Hope

Duarte, United States

Washington University School of Medicine

St Louis, United States

Roswell Park Cancer Institute

Buffalo, United States

Memorial Sloan Kettering Cancer Center - Bergen

New York, United States

Tennessee Oncology

Nashville, United States

Fred Hutchinson Cancer Center

Seattle, United States

Trial contact

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/26/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.